Cite
HARVARD Citation
Tinhofer, I. et al. (2016). The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer. Cancers of the head & neck. 1 (1), pp. 1-11. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tinhofer, I. et al. (2016). The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer. Cancers of the head & neck. 1 (1), pp. 1-11. [Online].